618 trials (keyword fallback)
Cervical Cancer
Primary: Cervical Cancer Screening — 198; 289 individuals screened — p=<0.001
Cervical Radiculopathy · Cervical Spondylosis · Disk, Herniated
Primary: Percentage of Participants Reporting ≥50% Reduction in Index Numeric Rating Scale (NRS) Arm Pain Score — 19; 23; 20; 20 Participants
Cervical Cancer
Primary: HPV Identification — 95; 142; 78 biopsies
Pain, Radiating
Primary: Avoidance of Neck Surgery — 24; 20; 3; 6 Participants
Cervical Pain
Primary: Percent of Peak Activation (%PA) — 51.72; 61.20; 88.1; 80.80 Percentage of Peak Activation (%PA)
Cervical Cancer · Cervical Intraepithelial Neoplasia Grade 1 · Human Papilloma Virus Infection
Primary: Complete Response - Clearance of Oncogenic Human Papillomavirus (HPV) and Complete Colposcopic, Histologic and Cytologic Clearance of Disease — 7; 6 participants
Cervical Cancer · Precancerous Condition
Primary: Number of Histopathologically Confirmed Cervical Intraepithelial Neoplasia (CIN)2+ Cases Associated With HPV16 and/or HPV18 Infection Detected in the Preceding Cervical…
Pancreatic Adenocarcinoma
Primary: Number of Subjects Completing Therapy Including Surgical Resection. — 107 Participants
Cervical Cancer Screening
Primary: Percentage of Cervical Cancer Screening — 40; 95 Participants
Cervical Cancer
Primary: Number of Participants Who Scheduled or Completed Cervical Cancer Screening — 28; 21 Participants
Intervertebral Disk Degeneration · Intervertebral Disk Displacement · Ossification of Posterior Longitudinal Ligament
Primary: Bone Fusion With CT(Postoperative 6 Months) — 26; 28 participants
Cervical Dysplasia
Primary: Sensitivity of Scanning a/LCI Probe to Detect Cervical Dysplasia as Measured by Percentage of Correctly Identified Positive Biopsies — 90.3; 100.0 percentage of correct…
Symptomatic Cervical Disc Disease
Primary: Individual Patient Overall Success — 127; 81; 67 participants
Cervical Radiculitis · Pain
Primary: Change in Strength in Both Groups After CESI. — 25; 30; 35; 30 Participants — p=.05
Systemic Lupus Erythematosus
Primary: Frequency of Participants With Adverse Events — 21; 33 Participants